Changes in Medical Privacy Rules Enacted

Publication
Article
OncologyONCOLOGY Vol 16 No 5
Volume 16
Issue 5

President Bush announced changes in the medical records privacy rule proposed by President Bill Clinton before he left office. Physicians do not have to comply with these rules until 2003.

President Bush announced changes in the medical recordsprivacy rule proposed by President Bill Clinton before he left office.Physicians do not have to comply with these rules until 2003. 

One major changeBush made was to specify that physicians and hospitals could, for the purposesof treatment, share medical information about patients with other physicians,hospitals, and providers, and provide medical services to the patientsthemselves, without prior consent. Rather, doctors and other health-careproviders must notify patients of privacy policies and make a "good faitheffort" to get written acknowledgment. 

Physicians had also been concernedabout the provision limiting the use of personal health information to the"minimum necessary." Doctors, patients, nurses, and others involved ina patient’s care feared that routine conversations could violate the rule. TheBush version would continue to cover oral communications and maintain the"minimum necessary" requirement, but would specify that doctors coulddiscuss a patient’s treatment with other professionals without the fear thattheir conversations could lead to a violation. As long as minimum necessarystandards are met and reasonable safeguards are taken to protect personal healthinformation, incidental disclosures would not be subject to penalties.

Recent Videos
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content